The appointments of Messrs. Fasola, Murray, Layton and Thomas to their new roles are effective today. As a practicing physician. Previously he served as Senior Vice President and Chief Information Officer for Humana, where he spent more than two decades in various technology and operational leadership roles. Together, today's appointments reinforce and accelerate Centene's longstanding commitment to providing high-quality, low-cost healthcare to members and increasing value to shareholders.". Chirag Patel M.D., is an internal medicine and pulmonary/critical care medicine physician, at Centene. Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health's Quality & Total Cost of Care business, providing end-to-end population health strategy and operational consulting to leading medical centers around the country. Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Im fortunate to continue seeing patients as part of my role at Centene, so scrubbing up and practicing good hand-washing hygiene is very familiar to me as an orthopedic surgeon. Centene Corporation (NYSE:NYSE:CNC) Q1 2023 Earnings Conference Call April 25, 2023 8:30 AM ETCompany ParticipantsJennifer Gilligan - Senior Vice President-Finance & Investor. Mr. Murray received his bachelor's degree in accounting from the University of Dayton and is a certified public accountant. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. Even after being vaccinated its important to follow all the expected CDC-recommended safety procedures. Jim Murray, EVP, Chief Operating Officer, Centene Corporation. Jim Murray, currently EVP, Chief Transformation Officer, will become EVP, Chief Operating Officer (COO), reporting to Mr. Fasola. In his role as President, Mr. Fasola brings more than three decades of successful leadership in the healthcare industry, including CEO roles at multiple health insurance companies. Alice Hm Chen, MD, MPH, serves as Chief Health Officer (CHO) for Centene Corporation. CENTENE CORP Compensation by Company Data Year: 2022 2021 2020 2019 Select Other Years For its 2022 fiscal year, CENTENE CORP, listed the following executives on its annual proxy statement to the SEC Equity Cash Compensation Other Fiscal Year Ended in 2022 Enter an executive or company name Previously, he was President and COO for Magellan Health where he oversaw the Magellan Behavioral and Specialty Health and Magellan Complete Care business segments. Onze According to Dr. Guerra, who is the current chair of an annual American Heart Association campaign in Kentucky, she naturally gravitates toward the Spanish-speaking community her cultural heritage being an important part of who she is. Alex Chen is chief medical officer at Health Net, LLC. "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. Centene.com uses cookies. corporate governance. Jim Murray, currently EVP, Chief Transformation Officer, will become EVP, Chief Operating Officer (COO), reporting to Mr. Fasola. Prior to that, he was Chairman, President, and CEO of HealthMarkets, Inc., one of the largest health insurance agencies and supplemental insurance companies in the U.S. HealthMarkets was acquired by UnitedHealth Group in 2019. A: Healthcare personnel continue to be on the front line of our country's battle against COVID-19. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. As part of her work with the Heart Association, shes participating in a Hispanic radio series, and shell be talking with her father, who is diabetic, about heart health. With extensive leadership and more than 20 years of experience in the managed care industry, Mr. Thomas will take on an expanded scope and responsibility for the Medicaid product and business development. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Brent Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with particular expertise in creating, scaling, and operating business in a highly regulated environment. Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. 418 followers 402 connections. The phased approach addresses and prioritizes vaccination for healthcare workers, people in long-term care facilities, and certain groups of essential workers and first responders. Prior to that he was a Vice President of Product Development at Alltel, a wireless service provider acquired by Verizon Wireless. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. Additionally, the Company announced the appointment of Alice H. Chen, MD, MPH, as Chief Health Officer (CHO), effective January 1, 2023, and Brian LeClaire, MBA, PhD, as Chief Information Officer (CIO), effective December 5, 2022. scusiamo se questo pu causarti degli inconvenienti. Lamentamos pelo inconveniente. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. Thank you, Rocco, and good morning, everyone. las molestias. Chief Medical Officer, Pharmacy, Innovation Merritt Island, Florida, United States. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on. Because of the language barrier, many Hispanic Kentuckians may have already faced health access issues, which is one of the reasons why the virus has had a disproportionate impact in this community, but Dr. Guerra has also noticed the impact that misinformation found on social media can have on compounding disparities. para informarnos de que tienes problemas. Our local approach allows us to help members access high-quality, culturally sensitive She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state's response to the COVID-19 pandemic. Prior to joining Centene, Brian LeClaire was Director, Technology, for the healthcare team at Arsenal Capital Partners, a private equity firm specializing in investments in healthcare and industrial growth companies. . As Centene's Chief Information Officer, Brooks is responsible for leading a team of more than 6000 employees and contractors that develops and implements software and services for health plan members. Our local approach allows us to help members access high-quality, culturally sensitive healthcare services. Lamentamos Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail As a practicing physician. Forward-Looking Statements real person. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Wir entschuldigen uns fr die Umstnde. Si vous continuez voir ce pour nous faire part du problme. As practicing physicians, our medical directors stay up to date on the best treatments and practices while understanding the needs of our members and those of the community. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, afterthe date hereof. Brent Layton, President and Chief Operating Officer of Centene, stated, "Sarah brings a tremendous skillset to the leadership of Centene Corporation, and I'm excited to partner closely with her as Centene begins our journey into the next era of our history. Dr. Chen received a Bachelor of Science in Environmental Biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Aiutaci a proteggere Glassdoor dimostrando che sei una persona reale. Salary information comes from 1 data point collected directly from employees, users, and past and present job advertisements on Indeed in the past 24 months. Brian LeClaire, Chief Information Officer, Centene Corporation. All forward-looking statements included in this press release are based on information available to us on the date hereof. Biography. Sunshine Health Appoints Nathan Landsbaum as CEO in Florida /PRNewswire/ -- Sunshine Health, a wholly owned subsidiary of Centene Corporation, is pleased to announce the appointment of Nathan. Dave joined Fidelis in 1999 as Director of Strategic Planning and Development and held positions of increasing responsibility during his tenure from Vice President, Senior Vice President of Operations, Senior Vice President and Chief Administrative Officer, and Executive Vice President and Chief Operating Officer culminating in leading the organization. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. "I also want to thank Michael Neidorff, Centene's visionary leader for more than 25 years. message, contactez-nous l'adresse Murray also served as Executive Vice President and Chief Operating Officer for Humana and held other significant leadership roles over a career spanning nearly three decades. ST. LOUIS, April 27, 2015 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced the appointment of Ken Yamaguchi, M.D., to Executive Vice President and Chief Medical Officer, effective . Transforming the health of the community, one person at a time. . Both individuals will report to Sarah London. "I am delighted that the Board has appointed Sarah as CEO. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. David P. Thomas, CEO, Markets and Medicaid, Centene Corporation. Biography. Dave joined Fidelis in 1999 as Director of Strategic Planning and Development and held positions of increasing responsibility during his tenure from Vice President, Senior Vice President of Operations, Senior Vice President and Chief Administrative Officer, and Executive Vice President and Chief Operating Officer culminating in leading the organization. Since Mr. Neidorff began a medical leave of absence in February 2022, she has been a member of the Office of the Chairman charged with running the day-to-day management of the Company. para nos informar sobre o problema. Mr. Fasola holds a Bachelor of Science in Health Planning and Administration from Pennsylvania State University and was named an Alumni Fellow in 2010. removing social barriers to health, and prioritizing responsible Aydanos a proteger Glassdoor y demustranos que eres una persona real. healthcare services. By continuing to use our site, you agree to our Privacy Policy and Terms and Conditions. Brent Layton will become Senior Advisor to the CEO, as he begins his transition towards retirement. She also has a Master of Public Health in Health Care Management and Policy from Harvard School of Public Health. om ons te informeren over dit probleem. message, please email Terms & Conditions. The health of individuals drives our focus on the environment, removing social barriers to health, and prioritizing . ein Mensch und keine Maschine sind. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Se continui a visualizzare In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments and the adequacy of our available cash resources. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Brent Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with particular expertise in creating, scaling, and operating business in a highly regulated environment. All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. He joined Centene through the acquisition of Magellan Health Inc (MGLN) where he served as CEO and a member of the Board of Directors. He served as CEO of Secure Horizons, a division of UnitedHealth Group and the nation's largest Medicare Advantage insurer. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Disculpa David P. Thomas, CEO, Markets and Medicaid, Centene Corporation. ", Drew Asher, Centene's Chief Financial Officer, said, "Sarah brings a modern vision to the helm of one of this country's most important healthcare companies. View original content:https://www.prnewswire.com/news-releases/centene-appoints-sarah-london-as-chief-executive-officer-301508299.html. Chief Health Officer. Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Dr. Felix L. Nuez is the chief medical officer (CMO) of GCHP, providing strategic direction, oversight, and evaluation of its medical programs. https://www.prnewswire.com/news-releases/centene-appoints-sarah-london-as-chief-executive-officer-301508299.html, Purchase Order Prior to that he was a Vice President of Product Development at Alltel, a wireless service provider acquired by Verizon Wireless. Previously, he was President and CEO of Fidelis Care where he led oversight across all divisions of Fidelis Care. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. A primary care internist by training, she provides clinical care at Zuckerberg San Francisco General Hospital. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the . In her new .